BrainCells
Biotechnology startup focused on drugs intended to stimulate the growth of new neurons.
Launch date
Employees
Market cap
-
Enterprise valuation
$16—24m (Dealroom.co estimates Aug 2011.)
San Diego California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$17.7m | Series A | ||
$30.0m | Series B | ||
$20.0m | Series B | ||
N/A | $995k | Debt | |
N/A | $4.0m | Early VC | |
N/A | $2.0m | Debt | |
Total Funding | $71.7m |
Recent News about BrainCells
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.